Compass Therapeutics Inc [CMPX] stock prices are saw in change for the day to $5.14 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CMPX shares have gain 3.63% over the last week, with a monthly amount glided 3.84%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Compass Therapeutics Inc [NASDAQ: CMPX] stock has seen the most recent analyst activity on December 03, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $10. On December 03, 2025, Canaccord Genuity initiated with a Buy rating and assigned a price target of $10 on the stock. Leerink Partners upgraded its rating to an Outperform but $6 remained the price target by the analyst firm on April 02, 2025. Guggenheim started tracking with a Buy rating for this stock on February 24, 2025, and assigned it a price target of $12. In a note dated February 19, 2025, Piper Sandler initiated an Overweight rating and provided a target price of $12 on this stock.
The stock price of Compass Therapeutics Inc [CMPX] has been fluctuating between $1.33 and $5.86 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $5.14 at the most recent close of the market. An investor can expect a potential return of 94.55% based on the average CMPX price forecast.
Analyzing the CMPX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.49 and Total Capital is -0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.04 points at the first support level, and at 4.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.22, and for the 2nd resistance point, it is at 5.30.
Ratios To Look Out For
It’s worth pointing out that Compass Therapeutics Inc [NASDAQ:CMPX]’s Current Ratio is 17.82. Further, the Quick Ratio stands at 17.82, while the Cash Ratio is 3.72.
Transactions by insiders
Recent insider trading involved Schuetz Thomas J., CHIEF EXECUTIVE OFFICER, that happened on May 27 ’25 when 10000.0 shares were purchased. Director, GORDON CARL L completed a deal on Apr 09 ’25 to sell 3.57 million shares. Meanwhile, Director ORBIMED ADVISORS LLC sold 3.57 million shares on Apr 09 ’25.
